Anzeige
Mehr »
Login
Dienstag, 16.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Biotech-Perle kurz vor entscheidender Meilenstein-Meldung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
96 Leser
Artikel bewerten:
(0)

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Numerex Acquisition - NMRX

BALA CYNWYD, PA / ACCESSWIRE / August 11, 2017 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Numerex Corp. ("Numerex" or "the Company") (NASDAQ: NMRX) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Sierra Wireless, Inc. ("Sierra").

Click here to learn more http://www.brodskysmith.com/cases/numerex-corp-nasdaq-nmrx/, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Numerex shareholders will receive only 0.18 of a share of Sierra for each share of Numerex stock they own. The transaction values Numerex stock at only approximately $4.12 per share. The investigation concerns whether the Board of Numerex breached their fiduciary duties to shareholders and whether Sierra is underpaying for the Company. The transaction may undervalue the Company and would result in a loss for many long-term holders of Numerex stock. For example, shares of Numerex stock have traded at $14.84 per share and an analyst has set an $5.50 per share price target for Numerex stock.

If you own shares of Numerex stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/numerex-corp-nasdaq-nmrx/, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.